CRIS Current Research Information System

G Martinelli, H Kantarjian, E Jabbour, A Quintás-Cardama, K Ando, J-O Bay, et al. (2012). Stage I findings of a two-stage Phase II study to assess the efficacy, safety and tolerability of barasertib (AZD1152) compared with low dose cytosine arabinoside in elderly patients with acute myeloid leukemia.

Stage I findings of a two-stage Phase II study to assess the efficacy, safety and tolerability of barasertib (AZD1152) compared with low dose cytosine arabinoside in elderly patients with acute myeloid leukemia

MARTINELLI, GIOVANNI;
2012
2012
JCO
6527
6527
G Martinelli, H Kantarjian, E Jabbour, A Quintás-Cardama, K Ando, J-O Bay, et al. (2012). Stage I findings of a two-stage Phase II study to assess the efficacy, safety and tolerability of barasertib (AZD1152) compared with low dose cytosine arabinoside in elderly patients with acute myeloid leukemia.
G Martinelli; H Kantarjian; E Jabbour; A Quintás-Cardama; K Ando; J-O Bay; A Wei;5 S Gröpper; K Owen; L Pike; N Schmitt; P Stockman; A Giagounidis; on...espandi
4.02 Riassunto (Abstract)
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/144083
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 1
social impact